The present invention relates to compound of formula (I), or stereoisomers and pharmaceutically acceptable salts as muscarinic M1 receptor positive allosteric modulators. This invention also relates to methods of preparing such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to muscarinic M1 receptor.
本发明涉及式(I)的化合物,或其立体异构体和药学上可接受的盐,作为肌
胆碱M1受体阳性变构调节剂。本发明还涉及制备这类化合物的方法和包含这类化合物的药物组合物。本发明的化合物在治疗与肌
胆碱M1受体相关的各种疾病方面是有用的。